Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual ([alpha]/[gamma]) Peroxisome Proliferator-Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: A double-blind, randomized, pioglitazone-comparative study
Kendall, David M, Rubin, Cindy J, Mohideen, Pharis, Ledeine, Jean-Marie, Belder, Rene, Gross, Jorge, Norwood, Paul, O'Mahony, Michael, Sall, Kenneth, Sloan, Greg, Roberts, Anthony, Fiedorek, Fred T, DeFronzo, Ralph A
Published in Diabetes care (01.05.2006)
Published in Diabetes care (01.05.2006)
Get full text
Journal Article
Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
Kendall, David M., Rubin, Cindy J., Mohideen, Pharis, Ledeine, Jean-Marie, Belder, Rene, Gross, Jorge, Norwood, Paul, O’Mahony, Michael, Sall, Kenneth, Sloan, Greg, Roberts, Anthony, Fiedorek, Fred T., DeFronzo, Ralph A.
Published in Diabetes care (01.05.2006)
Published in Diabetes care (01.05.2006)
Get full text
Journal Article
Muraglitazar, a dual (α/γ) PPAR activator: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes
Buse, John B., Rubin, Cindy J., Frederich, Robert, Viraswami-Appanna, Kalyanee, Lin, Kwo-Chuan, Montoro, Rafael, Shockey, Gerald, Davidson, Jaime A.
Published in Clinical therapeutics (01.08.2005)
Published in Clinical therapeutics (01.08.2005)
Get full text
Journal Article
Obesity in black adolescent girls: a controlled clinical trial of treatment by diet, behavior modification, and parental support
Wadden, T.A. (University of Pennsylvania School of Medicine, Philadelphia, PA), Stunkard, A.J, Rich, L, Rubin, C.J, Sweidel, G, McKinney, S
Published in Pediatrics (Evanston) (01.03.1990)
Published in Pediatrics (Evanston) (01.03.1990)
Get more information
Journal Article
Effects of Long-Term Therapy (2-Year) with Muraglitazar, a Novel Dual PPAR [alpha]/[gamma] Agonist, on Diabetic Dyslipidemia in Patients with Type 2 Diabetes: A Double-Blind, Randomized, Parallel-Group Study
Frederich, Robert, Viraswami-Appanna, Kalyanee, Rubin, Cindy J
Published in Diabetes (New York, N.Y.) (01.06.2005)
Get full text
Published in Diabetes (New York, N.Y.) (01.06.2005)
Journal Article
Glycemic Efficacy and Safety of Muraglitazar, a Novel Dual PPAR [alpha]/[gamma] Agonist, Plus Glyburide in Patients with Type 2 Diabetes Failing Sulfonylurea Monotherapy: A Randomized, Double-Blind, Placebo-Controlled Study
Pharis Mohideen, De Pril, Veerle, Rubin, Cindy J
Published in Diabetes (New York, N.Y.) (01.06.2005)
Get full text
Published in Diabetes (New York, N.Y.) (01.06.2005)
Journal Article
Improvement of Diabetic Dyslipidemia with Muraglitazar, a Novel Dual PPAR [alpha]/[gamma] Agonist, Plus Glyburide in Patients with Type 2 Diabetes Failing Sulfonylurea Monotherapy: A Randomized, Double-Blind, Placebo-Controlled Study
Pharis Mohideen, De Pril, Veerle, Rubin, Cindy J
Published in Diabetes (New York, N.Y.) (01.06.2005)
Get full text
Published in Diabetes (New York, N.Y.) (01.06.2005)
Journal Article
Attainment of A1C Goals with Muraglitazar, a Novel Dual PPAR [alpha]/[gamma] Agonist, in Combination with Metformin in Patients with Type 2 Diabetes: A Double-Blind, Randomized Comparison with Pioglitazone Plus Metformin
Rubin, Cindy J, Pharis Mohideen, Jean-Marie Ledeine, Belder, Rene, Fiedorek, Fred T
Published in Diabetes (New York, N.Y.) (01.06.2005)
Get full text
Published in Diabetes (New York, N.Y.) (01.06.2005)
Journal Article
Improvement of Glycemic Control with Muraglitazar, a Novel Dual PPAR [alpha]/[gamma] Agonist, in Combination with Metformin in Patients with Type 2 Diabetes: A Double-Blind, Randomized, Pioglitazone-Controlled Study
DeFronzo, Ralph A, Rubin, Cindy J, Pharis Mohideen, Jean-Marie Ledeine
Published in Diabetes (New York, N.Y.) (01.06.2005)
Get full text
Published in Diabetes (New York, N.Y.) (01.06.2005)
Journal Article
Abstract #866: Glycemic Efficacy and Tolerability of Muraglitazar, a Novel Dual Peroxisome Proliferator-Activated Receptor-Alpha/Gamma Agonist, in Drug-Naïve Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
Frederich, Robert, Viraswami-Appanna, Kalyanee, Rubin, Cindy J.
Published in Endocrine practice (01.03.2005)
Published in Endocrine practice (01.03.2005)
Get full text
Journal Article
Abstract #860: Glycemic Efficacy and Safety of Muraglitazar, a Novel Dual Peroxisome Proliferator-Activated Receptor-Alpha/Gamma Agonist, in Patients with Type 2 Diabetes: Results of a Double-Blind, Randomized, Parallel-Group, Dose-Comparison Study
Rubin, Cindy J., Viraswami-Appanna, Kalyanee, Fiedorek, Fred T.
Published in Endocrine practice (01.03.2005)
Published in Endocrine practice (01.03.2005)
Get full text
Journal Article